Payment overview · 2025
General Payments
$32.52
2 reported records · 2 companies
Healthcare provider profile · identity verified
Richard A Blatny, MD
Allopathic & Osteopathic Physicians|Family Medicine · FAIRBURY, NE · NPI 1699763003
Verified facts
What the public records show
CMS Open Payments records show Richard A Blatny, MD received $32.52 in general payments during 2025 across 2 reported records.
Esperion Therapeutics, Inc. accounted for 51.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $16.62 | 51.1% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.90 | 48.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.52 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $16.62 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $15.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 251 | 49 |
| Levothyroxine Sodium | Levothyroxine Sodium | 245 | 48 |
| Potassium Chloride | Potassium Chloride | 208 | 44 |
| Furosemide | Furosemide | 203 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 196 | 43 |
| Amlodipine Besylate | Amlodipine Besylate | 182 | 41 |
| Meloxicam | Meloxicam | 182 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 177 | 31 |
| Atorvastatin Calcium | Atorvastatin Calcium | 173 | 37 |
| Prednisone | Prednisone | 159 | 91 |
| Alprazolam | Alprazolam | 127 | 23 |
| Omeprazole | Omeprazole | 126 | 27 |
| Lisinopril | Lisinopril | 119 | 26 |
| Tramadol Hcl | Tramadol Hcl | 114 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 113 | 22 |
| Losartan Potassium | Losartan Potassium | 111 | 32 |
| Metformin Hcl | Metformin Hcl | 105 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 102 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 18 |
| Trazodone Hcl | Trazodone Hcl | 89 | 26 |
| Simvastatin | Simvastatin | 85 | 20 |
| Sertraline Hcl | Sertraline Hcl | 75 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 73 | 32 |
| Xarelto | Rivaroxaban | 63 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 61 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 57 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 57 | 11 |
| Spironolactone | Spironolactone | 57 | 11 |
| Warfarin Sodium | Warfarin Sodium | 57 | suppressed |
| Cefdinir | Cefdinir | 55 | 47 |
| Donepezil Hcl | Donepezil Hcl | 54 | suppressed |
| Eliquis | Apixaban | 54 | suppressed |
| Allopurinol | Allopurinol | 53 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 53 | 12 |
| Lorazepam | Lorazepam | 52 | 11 |
| Meclizine Hcl | Meclizine Hcl | 52 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 13 |
| Azithromycin | Azithromycin | 49 | 42 |
| Mirtazapine | Mirtazapine | 49 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 37 |
| Bupropion Xl | Bupropion Hcl | 44 | 12 |
| Sucralfate | Sucralfate | 44 | suppressed |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Ondansetron Odt | Ondansetron | 43 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 42 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 42 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 42 | 34 |
| Pregabalin | Pregabalin | 42 | suppressed |
| Glipizide | Glipizide | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Carvedilol | Carvedilol | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 27 |
| Fentanyl | Fentanyl | 29 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 17 |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Jardiance | Empagliflozin | 23 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 23 | suppressed |
| Baclofen | Baclofen | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Cephalexin | Cephalexin | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Famotidine | Famotidine | 19 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Etodolac | Etodolac | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.52 · 2 records | Esperion Therapeutics, Inc. | EVENITY, NEXLETOL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error